Journal Article

Chemoprevention of familial adenomatous polyposis development in the <i>APC</i><sup><i>min</i></sup> mouse model by 1,4-phenylene <i>bis</i>(methylene)selenocyanate

Chinthalapally V. Rao, Indranie Cooma, Jose G.Rosa Rodriguez, Barbara Simi, Karam El-Bayoumy and Bandaru S. Reddy

in Carcinogenesis

Volume 21, issue 4, pages 617-621
Published in print April 2000 | ISSN: 0143-3334
Published online April 2000 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/21.4.617
Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Epidemiological and experimental studies have suggested that dietary supplementation with selenium can inhibit the development of cancers at several organ sites. We have consistently shown that 1,4-phenylene bis(methylene) selenocyanate (p-XSC) is a highly effective cancer chemopreventive agent against the development of chemically induced cancers in several laboratory animal species. This is the first report describing the preventive effects of p-XSC in an animal model of familial adenomatous polyposis (FAP) containing a germline mutation of the APC gene. Six-week old male (heterozygous) C57BL/6J-APCmin or wild-type mice were fed high fat diets containing 0, 10 or 20 p.p.m. p-XSC. After 80 days, the mice were killed and their intestines were excised and evaluated for polyps. Multiple samples were also harvested from normal appearing small intestine and colon for molecular analysis. Both the mucosa and polyps from the intestine and colon were assayed for β-catenin, cyclooxygenase (COX)-2 expression and COX isoform activities. Administration of p-XSC in the diet significantly decreased the rate of formation of small intestinal tumors (P < 0.0001) and colon tumors (P < 0.002) in APCmin mice. p-XSC produced a dose-dependent inhibition of tumors in both small intestine (P < 0.0001) and colon (P < 0.035). Mice fed 20 p.p.m. p-XSC had significantly lower levels of β-catenin expression and COX-2 activity in polyps. These observations demonstrate for the first time that the synthetic organoselenium compound p-XSC possesses antitumor activity against genetically predisposed neoplastic lesions, such as FAP. While the exact mechanism(s) for this antitumor activity of p-XSC remains to be elucidated, it appears that modulation of β-catenin expression and COX-2 activity is associated with inhibition of intestinal polyps.

Keywords: AA, arachidonic acid; APC, adenomatous polyposis coli; COX, cyclooxygenase; FAP, familial adenomatous polyposis; HETE, hydroxyeicosatetraenoic acid; MTD, maximum tolerated dose; PG, prostaglandin; p-XSC, 1,4-phenylene bis(methylene)selenocyanate; SC, selenocysteine; SM, selenomethionine; Tcf, transcription factors.

Journal Article.  4325 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.